Telmijub AM-H 40 Tablet
Marketer
Jubilant Generics Limited
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmijub AM-H 40 Tablet
Amlodipine/Hydrochlorothiazide 40mg tablets are a dual-action medication prescribed for hypertension management when monotherapy proves insufficient. This combination lowers elevated blood pressure, thereby mitigating the risk of future cardiovascular events like stroke and heart attack. This medication may be taken with or without food; dosage is individualized based on patient response and condition. Consistent daily timing is recommended. Continued use, as directed by your physician, is crucial. The diuretic component increases urination; therefore, avoid dosing within four hours of bedtime. Regular use, even during symptom-free periods, maximizes therapeutic benefit. Hypertension often presents asymptomatically; discontinuation increases stroke and heart attack risk. Common side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential side effects such as dry mouth, thirst, and muscle weakness. Prior to commencing treatment, disclose any existing liver or kidney conditions. Pregnant or lactating individuals require physician consultation before initiating therapy. Inform your doctor about all concurrently used medications, particularly those for hypertension or heart conditions. Regular monitoring of blood pressure, renal function, electrolyte balance, and blood glucose levels is essential to ensure optimal treatment efficacy.
Primary Ingredients of Telmijub AM-H 40 Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Telmijub AM-H 40 Tablet
Elevated arterial blood pressure
Major Benefits of Telmijub AM-H 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmijub AM-H 40 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistency in timing is recommended.
Common Side effects of Telmijub AM-H 40 Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmijub AM-H 40 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmijub AM-H 40 Tablets can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Telmijub AM-H 40 Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide, combined as Telmijub AM-H 40 Tablet, offer a triple-action approach to blood pressure management. Telmisartan, an angiotensin receptor blocker (ARB), and Amlodipine, a calcium channel blocker (CCB), both promote vasodilation, leading to reduced blood pressure. Hydrochlorothiazide, a diuretic, contributes by eliminating excess fluid and electrolytes, further lowering pressure and enhancing circulation over time through its vasodilatory effects.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmijub AM-H 40 Tablet and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telmijub AM-H 40 Tablet during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
The use of Telmijub AM-H 40 Tablet while breastfeeding is contraindicated. Evidence indicates a potential for infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Telmijub AM-H 40 Tablet side effects. These potential side effects include dizziness, headaches, nausea, and fatigue, each of which can compromise concentration and safe driving.
KidneyCAUTION
Exercise caution when administering Telmijub AM-H 40 Tablet to individuals with severely impaired kidney function; dosage modification may be necessary. A physician's consultation is advised. Telmijub AM-H 40 Tablet is contraindicated in patients with severe renal insufficiency.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Telmijub AM-H 40 mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmijub AM-H 40 Tablet :
Should you forget a dose of Telmijub AM-H 40 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmijub AM-H 40 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |



